Radiomics-Driven Hybrid Deep Learning for MRI-Based Prediction of Glioma Grade and 1p/19q Codeletion
Tomography · 2026
DOI: 10.3390/tomography12020025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2026. Verfasst von Abdullah Bin Sawad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer and Information Technology, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Radiomics, Glioma, Deep Learning, Magnetic Resonance Imaging. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia, KAU Endowment (WAQF) at King Abdulaziz University, Jeddah, WAQF and the Deanship of Scientific Research.
Abstract (Originalsprache)
Background
Correct preoperative evaluation of glioma grade and molecular profile is a prerequisite for tailored treatment strategies. Specifically, the 1p/19q codeletion status represents a major prognostic and therapeutic marker in low-grade gliomas (LGGs). Nevertheless, its assessment is presently performed through invasive histopathological and genetic studies, thus underlining the need for non-invasive alternative approaches.
Methods
We introduce a non-invasive radiomics framework that combines quantitative MRI features with sophisticated ML and DL approaches for glioma grading and 1p/19q codeletion status prediction. High-dimensional radiomic features characterizing tumor geometry, intensity, and texture were derived from preoperative MRI-based tumor delineations. Features were normalized and optimized using correlation-based feature selection. Several traditional ML classifiers were compared and contrasted with DL models, such as convolutional neural networks (CNNs), recurrent neural networks (RNNs), and a CNN-Long Short-Term Memory (LSTM) hybrid model tailored to exploit both spatial feature hierarchies and feature correlations. Model validation was conducted using five-fold cross-validation and an independent test dataset, with accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) metrics.
Results
Among all the models tested, the hybrid CNN-LSTM model performed the best, with an accuracy of 88.1% and an AUC of 0.93, outperforming conventional ML approaches and single-model DL architectures. Explainability analysis showed that the radiomic features of tumor heterogeneity and morphology had the most prominent impact on model performance.
Conclusions
These findings indicate that the combination of radiomic features with hybrid DL models is capable of making non-invasive predictions of glioma grade and 1p/19q codeletion status. The new computational model has the potential to be used as a supplementary approach in precision neuro-oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer and Information Technology, The Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Department of Information Systems, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID-Profile: Muhammad Binsawad
Förderung
- Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia
- KAU Endowment (WAQF) at King Abdulaziz University, Jeddah
- WAQF and the Deanship of Scientific Research
Zitieren
APA
Sawad, A. B., & Binsawad, M. (2026). Radiomics-Driven Hybrid Deep Learning for MRI-Based Prediction of Glioma Grade and 1p/19q Codeletion. Tomography. https://doi.org/10.3390/tomography12020025
Vancouver
Sawad AB, Binsawad M. Radiomics-Driven Hybrid Deep Learning for MRI-Based Prediction of Glioma Grade and 1p/19q Codeletion. Tomography. 2026. doi:10.3390/tomography12020025
BibTeX
@article{Sawad2026,
author = {Sawad, Abdullah Bin and Binsawad, Muhammad},
title = {Radiomics-Driven Hybrid Deep Learning for MRI-Based Prediction of Glioma Grade and 1p/19q Codeletion},
journal = {Tomography},
year = {2026},
doi = {10.3390/tomography12020025}
}
EUVIMED